ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Diagnostics and tools companies at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

76 diagnostics and tools companies are at ESMO 2026 — 35 presentations on the program and 62 with a booth in the exhibit hall. Most represented: Medical Genetics Institute (5 on the program), Larvol (3 on the program), Chronomics (2 on the program). 64 of them have their own page in this guide. As of Nov 2, 2026.

All 1,879 organizations at ESMO 2026 →

Tumour type
Top represented
Showing 1–12 of 76 organizations
OrganizationESMO 2026 Attendance
MG
Medical Genetics Institute
Ho Chi Minh City, Vietnam
Diagnostics & tools
Genetics institute in Ho Chi Minh City, Vietnam, doing hereditary cancer testing and blood-based cancer detection research.
Satellite
Fri Oct 23
10:03–10:15
AI-enabled multi-omic cell-free DNA profiling for multi-cancer detection: technology principles, large validation datasets - Pathways to Global/Diverse Implementation
Gene Solutions - AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation
Biomarkers & precision oncology
Satellite
Fri Oct 23
10:39–10:47
3D Patient-Derived Organoids in Precision Medicine: From Bench to Bedside
Gene Solutions - AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation
Biomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Implementing comprehensive genomic profiling in Southeast Asia: Real-World feasibility and performance across multiple cancer types
Friday Poster Display session 3
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Real-world performance of dual tissue and liquid biopsy profiling for managing gastrointestinal and hepatobiliary cancers in Southeast Asia
Friday Poster Display session 3
Gastrointestinal cancersBiomarkers & precision oncology
Larvol
San Francisco, CA
Diagnostics & tools
Company providing artificial intelligence and data tools for oncology research and clinical decision support.
Poster
Fri Oct 23
13:00–15:00
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
A multi-LLM framework for oncology clinical decision support: A breast cancer case series
Sunday Poster Display session 1
Breast cancer
Poster
Sun Oct 25
12:00–12:45
LLM-based evidence scoring framework: 1L non-exon 20 EGFR-mutated advanced NSCLC as a case study
Sunday Poster Display session 1
Lung & thoracic cancers
Poster
Sun Oct 25
12:00–12:45
Multi-LLM–assisted trial selection for network meta-analysis in first-line extensive-stage small cell lung cancer
Sunday Poster Display session 1
Haematological malignancies
C
Chronomics
London, United Kingdom
Diagnostics & tools
Company developing data-driven health risk assessment and prediction tools.
Poster
Fri Oct 23
15:15–16:00
Poster
Sun Oct 25
12:00–12:45
Diagnostics & toolsExhibitor
Clinical laboratory company offering diagnostic testing, including oncology tests, and central-laboratory services for drug development.
Booth
Exhibiting at Booth 1088
Poster
Mon Oct 26
12:00–12:45
Histotype, mutational, and immune gene expression correlates of PD-L1 immunohistochemistry in real-world cohort of ovarian cancer cases
Monday Poster Display session 1
Gynaecological cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Validation of a multiparametric flow cytometry panel for quantifying CD20 expression in CLL whole blood during mosunetuzumab therapy
Monday Poster Display session 2
Haematological malignanciesBiomarkers & precision oncology
Abbott
Abbott Park, IL
Diagnostics & toolsExhibitor
Global healthcare company making diagnostics, medical devices and nutrition products; now owns Exact Sciences' cancer testing business.
Booth
Exhibiting at Booth 8071 · Exact Sciences
Poster
Fri Oct 23
13:00–15:00
Diagnostics & toolsExhibitor
Chinese precision oncology company offering cancer genomic profiling and early detection tests.
Booth
Exhibiting at Booth 8029
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Analytical validation of onco-transcan for whole-transcriptome RNA expression profiling and PAM50 subtyping in solid tumors
ePoster session 22
Breast cancerBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Clinical utility of FusionCapture RNA NGS for resolving ALK fusion variants to inform targeted therapy in lung cancer
ePoster session 17
Lung & thoracic cancersBiomarkers & precision oncology
Dxcover
Glasgow, United Kingdom
Diagnostics & tools
Develops liquid biopsy tests for early cancer detection.
Poster
Sun Oct 25
12:00–12:45
The evaluation of blood- and stool-based tests for the earlier detection of colorectal cancer
Sunday Poster Display session 5
Gastrointestinal cancers
Poster
Mon Oct 26
12:00–12:45
Evaluation of a multiomic liquid biopsy platform for high-sensitivity detection of ovarian cancer
Monday Poster Display session 1
Gynaecological cancersBiomarkers & precision oncology
SX
Shanghai Xiaohe Medical Laboratory
Shanghai, China
Diagnostics & tools
Medical laboratory company in Shanghai, China.
Poster
Mon Oct 26
12:00–12:45
A cell-free DNA methylation-based liquid biopsy for multi-cancer early detection (MCED) demonstrates excellent performance in neuroendocrine carcinomas (NECs)
Monday Poster Display session 3
Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Cell-free DNA (cfDNA) methylation-based liquid biopsy to stratifying aggressiveness of lung adenocarcinoma
Monday Poster Display session 3
Lung & thoracic cancersBiomarkers & precision oncology
Diagnostics & toolsExhibitor
Chinese maker of PCR and NGS companion diagnostic kits for cancer gene alterations.
Booth
Exhibiting at Booth 8059
Diagnostics & toolsExhibitor
Indian molecular diagnostics company making PCR and NGS test kits and instruments.
Booth
Exhibiting at Booth 1060
Poster
Fri Oct 23
13:00–15:00
Standardized CML detection and MRD monitoring using a lyophilized cold chain–free BCR-ABL RT-PCR assay on OnePCR and Rapi-Q platforms
ePoster session 13
Haematological malignanciesBiomarkers & precision oncology
Diagnostics & toolsExhibitor
Genetic testing company whose Signatera tumour-informed ctDNA test tracks molecular residual disease and treatment response.
Booth
Exhibiting at Booth 1015
Poster
Fri Oct 23
15:15–16:00
Plasma whole-exome sequencing (pWES) reveals somatic landscape and clonal dynamics in metastatic urothelial carcinoma
Friday Poster Display session 3
Genitourinary cancersBiomarkers & precision oncology
Diagnostics & toolsExhibitor
AI company building research agents and a biomedical knowledge base for drug development teams.
Booth
Exhibiting at Booth 1090

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from diagnostics and tools companies

Tell us what you sell and we’ll find the people at these diagnostics and tools companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ESMO 2026 by

Exhibit hall

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction